News Scotland's NHS to fund Ipsen cancer diarrhoea drug Decision welcomed as step forward for patients
News Pfizer will have to cut price of AML drug Mylotarg after NIC... NICE blocks access to 65% of patients on cost grounds
Partner Content Partner Content Jayne Hurrell joins OPEN Access Consulting as Director of Gl... Jayne Hurrell joins OPEN Access Consulting as Director
Partner Content Partner Content Matt De Gruchy joins Reynolds Mackenzie as new agency CEO Matt De Gruchy joins Reynolds Mackenzie as new CEO
Partner Content Partner Content Neil Levinson joins ACCRETIO as Strategy Director Neil Levinson joins ACCRETIO as Strategy Director
News Novartis/Amgen's migraine drug hits market at lower than exp... The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and at a lower than expected list price of $6,900.
News Dexcom is first to join FDA/CMS health tech pilot The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
